Patrick Bentley
Psychiatry · Medina, OHNPI 1386613719
Payments from drug & device makers
Across 170 payments — averaging $15.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$423
- Johnson & Johnson$380
- AbbVie$378
- Axsome Therapeutics, Inc.$306
- Alkermes, Inc.$293
- Neurocrine Biosciences, Inc.$224
- plus $592 from 8 others
What the payments were for
- Food & beverage$2,51497%
- Education$823%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $423 |
| Johnson & Johnson | 26 | $380 |
| AbbVie(2 entities) | 30 | $378 |
| Axsome Therapeutics, Inc. | 17 | $306 |
| Alkermes, Inc. | 21 | $293 |
| Neurocrine Biosciences, Inc. | 13 | $224 |
| Teva Pharmaceuticals USA, Inc. | 13 | $189 |
| Indivior Inc. | 11 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $76 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Lundbeck LLC | 2 | $35 |
| Noven Therapeutics, LLC | 2 | $26 |
| Corium, LLC | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
How this compares
$2,596 in reported general payments places this provider in the 80th percentile of 1,119 psychiatry providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 291 | $427,215 |
| IngrezzaValbenazine Tosylate | 22 | $172,154 |
| AuvelityDextromethorphan Hbr/Bupropion | 149 | $160,797 |
| Invega SustennaPaliperidone Palmitate | 54 | $139,084 |
| CaplytaLumateperone Tosylate | 48 | $72,234 |
| AristadaAripiprazole Lauroxil | 25 | $62,252 |
| Risperdal ConstaRisperidone Microspheres | 41 | $40,345 |
| LybalviOlanzapine/Samidorphan Malate | 19 | $32,178 |
| PerserisRisperidone | 13 | $29,394 |
| RexultiBrexpiprazole | 19 | $29,059 |
| Aripiprazole | 338 | $25,457 |
| BelsomraSuvorexant | 46 | $20,507 |
| Lurasidone Hcl | 51 | $18,803 |
| VyvanseLisdexamfetamine Dimesylate | 37 | $14,380 |
| Olanzapine-Fluoxetine HclOlanzapine/Fluoxetine Hcl | 54 | $11,045 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $378 | $427,215291 claims |
| Johnson & JohnsonInvega Sustenna, Risperdal Consta | $380 | $179,42995 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $224 | $172,15422 claims |
| Axsome Therapeutics, Inc.Auvelity | $306 | $160,797149 claims |
| Alkermes, Inc.Aristada, Lybalvi | $293 | $94,43044 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $423 | $72,23448 claims |
| Indivior Inc.Perseris | $170 | $29,39413 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $66 | $29,05919 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix | $76 | $23,15455 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,119 psychiatry providers in Ohio.
Other psychiatry in Medina
- Rakesh RanjanMedina$714K
- Shishuka MalhotraCanton$15M
- Henry NasrallahCincinnati$3.8M
- Otto DuenoDayton$3.1M
- Diab AlmhanaAvon Lake$2.7M
- Mohamed Abdel AzizWest Chester$2.6M
- Fred RomeoColumbus$2.3M
- Mark WoyshvilleMiddleburg Heights$2.2M
- Amita PatelDayton$2.1M
- Caleb AdlerCincinnati$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.